Decisions about treatment with a cholinesterase inhibitor should be individualized and based on the informed consent/assent of the patient. At follow-up visits the patient has to be assessed for ...

In contrast to previous reviews that have predominantly focused on a singular biological activity associated with these molecules, this review consolidates findings from various investigations ...

Getting diagnosed with Alzheimer's disease affects one's life expectancy. However, there are various factors that can ...

Due, in part, to the logical nature of the approach, combination therapy is already widely used in clinical practice. Although compounds with a combined cholinergic–glutamatergic action have ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...